Stemtech Corporation (STEK)
OTCMKTS · Delayed Price · Currency is USD
0.0277
-0.0038 (-12.19%)
Jul 18, 2025, 4:00 PM EDT
Stemtech Revenue
In the year 2024, Stemtech had annual revenue of $5.05M with 2.69% growth. Stemtech had revenue of $1.31M in the quarter ending December 31, 2024, a decrease of -3.53%.
Revenue
5.05M
Revenue Growth
+2.69%
P/S Ratio
0.87
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.94M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Stemtech News
- 4 days ago - Stemtech Corporation Announces Leading Clinical Physician To Research the Values of Stemtech RCM Products - Accesswire
- 6 weeks ago - Stemtech Corporation Announces Dr. Lizette Leos' "Well-Aging" Video Series - Accesswire
- 7 weeks ago - Stemtech Launches "StemPets(TM)" - the All-Natural Longevity Nutraceuticals Developed for Pets - Accesswire
- 4 months ago - Stemtech Corporation Announces Strategic Leadership Additions and Milestones Toward StemPets(TM) Launch in 2025 - Accesswire
- 5 months ago - Stemtech Corporation: Leading The Global Wellness - Anti-Aging Healthy Revolution - Accesswire
- 8 months ago - Stemtech Corporation / Viago and Eevia Health Announce Proposed RTO - Accesswire
- 8 months ago - Stemtech Corporation and Seacret Direct / Viago Execute Merger Agreement - Accesswire
- 8 months ago - Stemtech Corporation and Viago Announce Strategic Merger - Accesswire